Pooled analysis of tanezumab efficacy and safety with subgroup analyses of phase III clinical trials in patients with osteoarthritis pain of the knee or hip

Overview of attention for article published in Journal of Pain Research, March 2019

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 42 Dimensions

Readers on

mendeley: 61 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 42 publications that cite this research output.

42

The most recent citing publications are shown below. View all 42 publications that cite this research output on Dimensions.

JAK-STAT Signaling and Beyond in the Pathogenesis of Spondyloarthritis and Their Clinical Significance

Article in Current Rheumatology Reports (March 2024)

Molecular pathogenesis of OA pain: Past, present, and future

Article in Osteoarthritis and Cartilage (January 2024)

Peripheral Nerve Safety of Nerve Growth Factor Inhibition by Tanezumab: Pooled Analyses of Phase III Clinical Studies in Over 5000 Patients with Osteoarthritis

Article in Clinical Drug Investigation (July 2023)